PTH concentrations are routinely measured in the diagnosis and management of bone and mineral disease and chronic kidney disease (CKD) [3, 4]; however, the target range for PTH may vary significantly depending on vitamin D status, defined as the sum of 25(OH)D2 and 25(OH)D3 circulating levels [5, 6]. This evidence concerns the gene PTH and chronic kidney disease.